Evidence map›Paper›PMID 32372988›Full record

ArticleFrontiers in psychiatry2020

No Impact of Omega-3 Fatty Acid Supplementation on Symptoms or Hostility Among Patients With Schizophrenia.

Yi Qiao, Cai Ping Liu, Hui Qin Han, Feng Ju Liu, Yang Shao, Bin Xie

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 4 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 4 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yi QiaoShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Cai Ping LiuShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Hui Qin HanShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Feng Ju LiuShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yang ShaoShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Bin XieShanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Mental Health Center · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study was aimed to explore the impact of fish oil (Omega-3 fatty acids) on hostility and psychopathology among patients with acute violent schizophrenia.

methodSixty seven acute hospitalized patients demonstrating violent behavior in the context of a schizophrenic illness, treated with antipsychotics, were randomly assigned to a supplement with either fish oil (N=32) or placebo (N=35) in a double-blind, placebo-controlled trial. Assessments were conducted at the baseline, week 4 and week 8.

resultsThe symptoms and hostility decreased after treatment for 4 and 8 weeks in both groups, with no group differences.

conclusionsThe current study did not find improvements in symptoms or hostility from the Omega-3 fatty acid supplementation in patients with schizophrenia. The implication is that Omega-3 fatty acids do not reduce psychopathology and hostility in acute patients with schizophrenia.

Indexed as

hostilityomega-3psychopathologyrandomized control trialschizophrenia

Identifiers

PMID32372988
PMCPMC7186329
OpenAlexW3018066838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.